Number of metabolic syndrome traits adds little to prediction of major adverse liver outcomes on top of FIB-4 in patients with type 2 diabetes

Diabetes Epidemiology and Management · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles